Position
ALGERT GLOBAL LLC in Cullinan Therapeutics, Inc.
Back to the book · All holders of CGEM
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $423$0.01 → $0.01
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 162.5K | $1.68K | — | — | — | 0.0% |
| Q1 2026 | 109.7K | $1.56K | $0.01 | $423 | −$546 | 0.0% |